Immune Profile and Clinical Outcome of Breakthrough Cases After Vaccination With an Inactivated SARS-CoV-2 Vaccine

Immune Profile and Clinical Outcome of Breakthrough Cases After Vaccination With an Inactivated SARS-CoV-2 Vaccine

Constant efforts to prevent infections by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are actively carried out around the world. Several vaccines are currently approved for emergency use in the population, while ongoing studies continue to provide information on their safety and eff...

Full description

Bibliographic Details
Main Authors: Luisa F. Duarte, Nicolás M. S. Gálvez, Carolina Iturriaga, Felipe Melo-González, Jorge A. Soto, Bárbara M. Schultz, Marcela Urzúa, Liliana A. González, Yaneisi Vázquez, Mariana Ríos, Roslye V. Berríos-Rojas, Daniela Rivera-Pérez, Daniela Moreno-Tapia, Gaspar A. Pacheco, Omar P. Vallejos, Guillermo Hoppe-Elsholz, María S. Navarrete, Álvaro Rojas, Rodrigo A. Fasce, Jorge Fernández, Judith Mora, Eugenio Ramírez, Gang Zeng, Weining Meng, José V. González-Aramundiz, Pablo A. González, Katia Abarca, Susan M. Bueno, Alexis M. Kalergis
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Immunology
Subjects:
CoronaVac
phase 3 clinical trial
SARS-CoV-2
COVID-19
vaccines
breakthrough cases
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.742914/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.742914/full

Similar Items